{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:16:47Z","timestamp":1794734207821,"version":"4.9.1"},"reference-count":162,"publisher":"Bentham Science Publishers Ltd.","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Diabetes is a chronic, irreversible, non-infectious metabolic syndrome associated with\nlow insulin production by the pancreas or due to insulin resistance. The management landscape\nfor diabetes is swiftly evolving due to ongoing advancements. Conventional treatment approaches\nhave struggled to fully address the root causes of the disease while also carrying significant risks\nof adverse effects. Flavonoids are an extensive class of phytonutrients present in grains, vegetables,\nfruits, cocoa, tea, wine, and nuts. Many studies have reported that flavonoids have shown diversified\npharmacological activity in recent years. Thus, this review will give you an overview of\nthe significant anti-diabetic potential of promising flavonoids. Various search engines such as\nPubMed, Scopus, Google Scholar, and WoS have been explored by using the keywords \u201capigenin,\u201d\n\u201cluteolin,\u201d \u201cnaringenin,\u201d \u201chesperidin,\u201d \u201ckaempferol,\u201d \u201cquercetin,\u201d \u201cmyricetin\u201d and \u201ctaxifolin\u201d\nwith \u201canti-diabetic.\u201d The anti-diabetic activity of flavonoids is attributed to various mechanisms,\nincluding \u03b1 glucosidase, \u03b1-amylase inhibitory effects, GLUT4 expression, antioxidant, and apoptosis.\nHowever, their inadequate biopharmaceutical qualities make their effectiveness in clinical\ntranslation constrained. This review aims to highlight plant-derived flavonoids through in-vitro, in\nvivo, and clinical insights. Additionally, the review highlights the recent advancement in the drug\ndelivery system in diabetes to overcome the limitation of flavonoids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115733998335480241022084655","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:21:47Z","timestamp":1733120507000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Mechanism-based Perspective on the Use of Flavonoids in the Treatment of Diabetes and its Complications"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5441-4637","authenticated-orcid":true,"given":"Sandesh Kumar","family":"Pattanaik","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha \u2018O\u2019 Anusandhan Deemed to be University, Bhubaneswar, Odisha, 751003,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-9462","authenticated-orcid":true,"given":"Manisha Prajapati","family":"Anil","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sharda University, Knowledge Park-3, Greater Noida, U.P., 201306, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-6185","authenticated-orcid":true,"given":"Sudipta","family":"Jena","sequence":"additional","affiliation":[{"name":"Centre of\nBiotechnology, Siksha \u2018O\u2019 Anusandhan Deemed to be University, Bhubaneswar, Odisha, 751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-084X","authenticated-orcid":true,"given":"Diptirani","family":"Rath","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha \u2018O\u2019 Anusandhan Deemed to be University, Bhubaneswar, Odisha, 751003,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"Ong K.L.","year":"2023","unstructured":"Ong K.L.; Stafford L.K.; McLaughlin S.A.; Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet  2023,402(10397),203-234","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"Sun H.","year":"2022","unstructured":"Sun H.; Saeedi P.; Karuranga S.; Pinkepank M.; Ogurtsova K.; Duncan B.B.; Stein C.; Basit A.; Chan J.C.N.; Mbanya J.C.; Pavkov M.E.; Ramachandaran A.; Wild S.H.; James S.; Herman W.H.; Zhang P.; Bommer C.; Kuo S.; Boyko E.J.; Magliano D.J.; IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract  2022,183,109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"748157","DOI":"10.3389\/fpubh.2022.748157","volume":"10","author":"Mathur P.","year":"2022","unstructured":"Mathur P.; Leburu S.; Kulothungan V.; Prevalence, awareness, treatment and control of diabetes in india from the countrywide national NCD monitoring survey. Front Public Health  2022,10,748157","journal-title":"Front Public Health"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/9781681080369115010011","author":"Baker C.","year":"2015","unstructured":"Baker C.; Is it type 1 or type 2? It may not be so easy. Obesity and Disease in an Interconnected World  2015,102-113","journal-title":"Obesity and Disease in an Interconnected World"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e2004","DOI":"10.1002\/hsr2.2004","volume":"7","author":"Hossain M.J.","year":"2024","unstructured":"Hossain M.J.; Al-Mamun M.; Islam M.R.; Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep  2024,7(3),e2004","journal-title":"Health Sci Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.preghy.2021.05.004","volume":"25","author":"Sole K.B.","year":"2021","unstructured":"Sole K.B.; Staff A.C.; Laine K.; Maternal diseases and risk of hypertensive disorders of pregnancy across gestational age groups. Pregnancy Hypertens  2021,25,25-33","journal-title":"Pregnancy Hypertens"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.hsr.2023.100086","volume":"7","author":"Shamsad A.","year":"2023","unstructured":"Shamsad A.; Kushwah A.S.; Singh R.; Banerjee M.; Pharmaco-epi-genetic and patho-physiology of gestational diabetes mellitus (GDM): An overview. Health Sci Rev (Oxf)  2023,7,100086","journal-title":"Health Sci Rev (Oxf)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijpb13010003","volume":"13","author":"Twaij B.M.","year":"2022","unstructured":"Twaij B.M.; Hasan M.N.; Bioactive secondary metabolites from plant sources: Types, synthesis, and their therapeutic uses. Int J Plant Biol  2022,13(1),4-14","journal-title":"Int J Plant Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2174\/1389200221999200728144801","volume":"21","author":"Riaz A.","year":"2020","unstructured":"Riaz A.; Rasul A.; Kanwal N.; Hussain G.; Shah M.A.; Sarfraz I.; Ishfaq R.; Batool R.; Rukhsar F.; Adem \u015e.; Germacrone: A potent secondary metabolite with therapeutic potential in metabolic diseases, cancer and viral infections. Curr Drug Metab  2020,21(14),1079-1090","journal-title":"Curr Drug Metab"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.jarmap.2020.100255","volume":"18","author":"Mahajan M.","year":"2020","unstructured":"Mahajan M.; Kuiry R.; Pal P.K.; Understanding the consequence of environmental stress for accumulation of secondary metabolites in medicinal and aromatic plants. J Appl Res Med Aromat Plants  2020,18,100255","journal-title":"J Appl Res Med Aromat Plants"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e160123212750","DOI":"10.2174\/1573399819666230116111856","volume":"19","author":"Li L.Z.","year":"2023","unstructured":"Li L.Z.; Yan Y.; Song Q.; Wang Z.; Zhang W.; Hou Y.; Zhang X.; Impacts of plant-derived secondary metabolites for improving flora in type 2 diabetes. Curr Diabetes Rev  2023,19(7),e160123212750","journal-title":"Curr Diabetes Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"990063","DOI":"10.3389\/fcvm.2022.990063","volume":"9","author":"Soltani D.","year":"2022","unstructured":"Soltani D.; Azizi B.; Rahimi R.; Talasaz A.H.; Rezaeizadeh H.; Vasheghani-Farahani A.; Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence. Front Cardiovasc Med  2022,9,990063","journal-title":"Front Cardiovasc Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13659-020-00281-x","volume":"11","author":"Verma T.","year":"2021","unstructured":"Verma T.; Sinha M.; Bansal N.; Yadav S.R.; Shah K.; Chauhan N.S.; Plants used as antihypertensive. Nat Prod Bioprospect  2021,11(2),155-184","journal-title":"Nat Prod Bioprospect"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/DDDT.S446949","volume":"18","author":"Prayoga D.","year":"2024","unstructured":"Prayoga D.; Aulifa D.; Budiman A.; Levita J.; Plants with anti-ulcer activity and mechanism: A review of preclinical and clinical studies. Drug Des Devel Ther  2024,18,193-213","journal-title":"Drug Des Devel Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12936-020-03231-7","volume":"19","author":"Bekono B.D.","year":"2020","unstructured":"Bekono B.D.; Ntie-Kang F.; Ongu\u00e9n\u00e9 P.A.; Lifongo L.L.; Sippl W.; Fester K.; Owono L.C.O.; The potential of anti-malarial compounds derived from African medicinal plants: A review of pharmacological evaluations from 2013 to 2019. Malar J  2020,19(1),183","journal-title":"Malar J"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"105961","DOI":"10.1016\/j.phrs.2021.105961","volume":"177","author":"Fakhri S.","year":"2022","unstructured":"Fakhri S.; Moradi S.Z.; Ash-Rafzadeh A.; Bishayee A.; Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review. Pharmacol Res  2022,177,105961","journal-title":"Pharmacol Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/ptr.8147","volume":"38","author":"Yuandani J.I.","year":"2024","unstructured":"Yuandani J.I.; Jantan I.; Salim E.; Septama A.W.; Rullah K.; Nainu F.; Fasihi Mohd Aluwi M.F.; Emran T.B.; Roney M.; Khairunnisa N.A.; Nasution H.R.; Fadhil As\u2019ad M.; Shamsudin N.F.; Abdullah M.A.; Marwa Rani H.L.; Al Chaira D.M.; Aulia N.; Mechanistic insights into anti-inflammatory and immunosuppressive effects of plant secondary metabolites and their therapeutic potential for rheumatoid arthritis. Phytother Res  2024,38(6),2931-2961","journal-title":"Phytother Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"102230","DOI":"10.1016\/j.fbio.2022.102230","volume":"51","author":"Ghosh S.","year":"2023","unstructured":"Ghosh S.; Sarkar T.; Chakraborty R.; Ankol plant (Alangium salvifolium) - The treasure trove of bioactives and medicinal potential. Food Biosci  2023,51,102230","journal-title":"Food Biosci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.plaphy.2021.08.001","volume":"167","author":"Chamkhi I.","year":"2021","unstructured":"Chamkhi I.; Benali T.; Aanniz T.; El Menyiy N.; Guaouguaou F.E.; El Omari N.; El-Shazly M.; Zengin G.; Bouyahya A.; Plant-microbial interaction: The mechanism and the application of microbial elicitor induced secondary metabolites biosynthesis in medicinal plants. Plant Physiol Biochem  2021,167,269-295","journal-title":"Plant Physiol Biochem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"020188","DOI":"10.1063\/5.0163351","volume":"2800","author":"Pattanaik S.K.","year":"2023","unstructured":"Pattanaik S.K.; Anil P.M.; Patyar S.; Underlying mechanisms of Astragalus membranaceus in the treatment of multiple-sclerosis. RE:view  2023,2800,020188","journal-title":"RE:view"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1080\/1028415X.2020.1840035","volume":"25","author":"Chen B.","year":"2022","unstructured":"Chen B.; Zhao J.; Zhang R.; Zhang L.; Zhang Q.; Yang H.; An J.; Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis. Nutr Neurosci  2022,25(5),1078-1099","journal-title":"Nutr Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-24274-3_5","author":"Teoh E.S.","year":"2016","unstructured":"Teoh E.S.; Secondary metabolites of plants. Medicinal Orchids of Asia  2016,59-73","journal-title":"Medicinal Orchids of Asia"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"102712","DOI":"10.1016\/j.bcab.2023.102712","volume":"50","author":"Adhikary S.","year":"2023","unstructured":"Adhikary S.; Dasgupta N.; Role of secondary metabolites in plant homeostasis during biotic stress. Biocatal Agric Biotechnol  2023,50,102712","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43088-020-00065-9","volume":"9","author":"Ekalu A.","year":"2020","unstructured":"Ekalu A.; Habila J.D.; Flavonoids: Isolation, characterization, and health benefits. Beni Suef Univ J Basic Appl Sci  2020,9(1),45","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/biom9090430","volume":"9","author":"AL-Ishaq R.K.","year":"2019","unstructured":"AL-Ishaq R.K.; Abotaleb M.; Kubatka P.; Kajo K.; B\u00fcsselberg D.; Flavonoids and their anti-diabetic effects: Cellular mechanisms and effects to improve blood sugar levels. Biomolecules  2019,9(9),430","journal-title":"Biomolecules"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1080\/10408398.2021.1919051","volume":"62","author":"Oliveira A.K.S.","year":"2022","unstructured":"Oliveira A.K.S.; de Oliveira e Silva A.M.; Pereira R.O.; Santos A.S.; Barbosa Junior E.V.; Bezerra M.T.; Barreto R.S.S.; Quintans-Junior L.J.; Quintans J.S.S.; Anti-obesity properties and mechanism of action of flavonoids: A review. Crit Rev Food Sci Nutr  2022,62(28),7827-7848","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"155535","DOI":"10.1016\/j.phymed.2024.155535","volume":"128","author":"Zhang J.","year":"2024","unstructured":"Zhang J.; Mao-mao ; Shao M.; Wang M.; Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review. Phytomedicine  2024,128,155535","journal-title":"Phytomedicine"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.crphar.2023.100167","volume":"6","author":"Mir S.A.","year":"2024","unstructured":"Mir S.A.; Dar A.; Hamid L.; Nisar N.; Malik J.A.; Ali T.; Bader G.N.; Flavonoids as promising molecules in the cancer therapy: An insight. Curr Res Pharmacol Drug Discov  2024,6,100167","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.biopha.2017.01.060","volume":"88","author":"Lv D.","year":"2017","unstructured":"Lv D.; Cheng X.; Tang L.; Jiang M.; The cardioprotective effect of total flavonoids on myocardial ischemia\/reperfusion in rats. Biomed Pharmacother  2017,88,277-284","journal-title":"Biomed Pharmacother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e21849","DOI":"10.1016\/j.heliyon.2023.e21849","volume":"9","author":"Ebrahimi F.","year":"2023","unstructured":"Ebrahimi F.; Ghazimoradi M.M.; Fatima G.; Bahramsoltani R.; Citrus flavonoids and adhesion molecules: Potential role in the management of atherosclerosis. Heliyon  2023,9(11),e21849","journal-title":"Heliyon"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12967-024-04949-7","volume":"22","author":"Wu R.","year":"2024","unstructured":"Wu R.; Zhu X.; Guan G.; Cui Q.; Zhu L.; Xing Y.; Zhao J.; Association of dietary flavonoid intakes with prevalence of chronic respiratory diseases in adults. J Transl Med  2024,22(1),205","journal-title":"J Transl Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00417-015-3168-y","volume":"253","author":"Patel S.","year":"2015","unstructured":"Patel S.; Mathan J.J.; Vaghefi E.; Braakhuis A.J.; The effect of flavonoids on visual function in patients with glaucoma or ocular hypertension: A systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol  2015,253(11),1841-1850","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3892\/mmr.2024.13256","volume":"30","author":"Liu F.","year":"2024","unstructured":"Liu F.; Bai Y.; Wan Y.; He J.; Li Q.; Xie Y.; Guo P.; Mechanism of flavonoids in the treatment of gouty arthritis (Review). Mol Med Rep  2024,30(2),132","journal-title":"Mol Med Rep"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3389\/fphar.2019.01295","volume":"10","author":"Choy K.W.","year":"2019","unstructured":"Choy K.W.; Murugan D.; Leong X.F.; Abas R.; Alias A.; Mustafa M.R.; Flavonoids as natural anti-inflammatory agents targeting nuclear factor-kappa B (NF\u03baB) signaling in cardiovascular diseases: A mini review. Front Pharmacol  2019,10,1295","journal-title":"Front Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.3390\/molecules28134982","volume":"28","author":"Chen S.","year":"2023","unstructured":"Chen S.; Wang X.; Cheng Y.; Gao H.; Chen X.; A review of classification, biosynthesis, biological activities and potential applications of flavonoids. Molecules  2023,28(13),4982","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jnutbio.2013.06.003","volume":"24","author":"Babu P.V.A.","year":"2013","unstructured":"Babu P.V.A.; Liu D.; Gilbert E.R.; Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem  2013,24(11),1777-1789","journal-title":"J Nutr Biochem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1080\/10408398.2020.1862755","volume":"62","author":"Proen\u00e7a C.","year":"2022","unstructured":"Proen\u00e7a C.; Ribeiro D.; Freitas M.; Fernandes E.; Flavonoids as potential agents in the management of type 2 diabetes through the modulation of \u03b1-amylase and \u03b1-glucosidase activity: A review. Crit Rev Food Sci Nutr  2022,62(12),3137-3207","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1080\/10408398.2015.1032400","volume":"57","author":"Xiao J.","year":"2015","unstructured":"Xiao J.; Dietary flavonoid aglycones and their glycosides: Which show better biological significance? Crit Rev Food Sci Nutr  2015,57(9),1874-1905","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/157339913804143225","volume":"9","author":"Fu Z.","year":"2013","unstructured":"Fu Z.; Gilbert E.R.; Liu D.; Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Curr Diabetes Rev  2013,9(1),25-53","journal-title":"Curr Diabetes Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.3390\/ijms22126403","volume":"22","author":"Rahman M.S.","year":"2021","unstructured":"Rahman M.S.; Hossain K.S.; Das S.; Kundu S.; Adegoke E.O.; Rahman M.A.; Hannan M.A.; Uddin M.J.; Pang M.G.; Role of insulin in health and disease: An update. Int J Mol Sci  2021,22(12),6403","journal-title":"Int J Mol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"Rui L.","year":"2014","unstructured":"Rui L.; Energy metabolism in the liver. Compr Physiol  2014,4(1),177-197","journal-title":"Compr Physiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fendo.2020.00378","volume":"11","author":"Whitticar N.B.","year":"2020","unstructured":"Whitticar N.B.; Nunemaker C.S.; Reducing glucokinase activity to enhance insulin secretion: A counterintuitive theory to preserve cellular function and glucose homeostasis. Front Endocrinol (Lausanne)  2020,11,378","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"115734","DOI":"10.1016\/j.biopha.2023.115734","volume":"168","author":"Antar S.A.","year":"2023","unstructured":"Antar S.A.; Ashour N.A.; Sharaky M.; Khattab M.; Ashour N.A.; Zaid R.T.; Roh E.J.; Elkamhawy A.; Al-Karmalawy A.A.; Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother  2023,168,115734","journal-title":"Biomed Pharmacother"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/7297419","volume":"2021","author":"Velikova T.V.","year":"2021","unstructured":"Velikova T.V.; Kabakchieva P.P.; Assyov Y.S.; Georgiev T.\u0410.; Targeting inflammatory cytokines to improve type 2 diabetes control. BioMed Res Int  2021,2021,1-12","journal-title":"BioMed Res Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.2337\/dcS15-3015","volume":"39","author":"Pollack R.M.","year":"2016","unstructured":"Pollack R.M.; Donath M.Y.; LeRoith D.; Leibowitz G.; Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care  2016,39(Suppl. 2),S244-S252","journal-title":"Diabetes Care"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","volume":"14","author":"Tsalamandris S.","year":"2019","unstructured":"Tsalamandris S.; Antonopoulos A.S.; Oikonomou E.; Papamikroulis G.A.; Vogiatzi G.; Papaioannou S.; Deftereos S.; Tousoulis D.; The role of inflammation in diabetes: Current concepts and future perspectives. Eur Cardiol  2019,14(1),50-59","journal-title":"Eur Cardiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/biomedicines10051168","volume":"10","author":"Nedosugova L.V.","year":"2022","unstructured":"Nedosugova L.V.; Markina Y.V.; Bochkareva L.A.; Kuzina I.A.; Petunina N.A.; Yudina I.Y.; Kirichenko T.V.; Inflammatory mechanisms of diabetes and its vascular complications. Biomedicines  2022,10(5),1168","journal-title":"Biomedicines"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/nu12103211","volume":"12","author":"van Sloun B.","year":"2020","unstructured":"van Sloun B.; Goossens G.; Erdos B.; Lenz M.; van Riel N.; Arts I.; The impact of amino acids on postprandial glucose and insulin kinetics in humans: A quantitative overview. Nutrients  2020,12(10),3211","journal-title":"Nutrients"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3390\/jcm12186053","volume":"12","author":"Tanase D.M.","year":"2023","unstructured":"Tanase D.M.; Gosav E.M.; Botoc T.; Floria M.; Tarniceriu C.C.; Maranduca M.A.; Haisan A.; Cucu A.I.; Rezus C.; Costea C.F.; Depiction of Branched-Chain Amino Acids (BCAAs) in diabetes with a focus on diabetic microvascular complications. J Clin Med  2023,12(18),6053","journal-title":"J Clin Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/nu13072229","volume":"13","author":"Zakaria N.F.","year":"2021","unstructured":"Zakaria N.F.; Hamid M.; Khayat M.E.; Amino acid-induced impairment of insulin signaling and involvement of G-protein coupling receptor. Nutrients  2021,13(7),2229","journal-title":"Nutrients"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/cells12030460","volume":"12","author":"Kozie\u0142 K.","year":"2023","unstructured":"Kozie\u0142 K.; Urbanska E.M.; Kynurenine pathway in diabetes mellitus - Novel pharmacological target? Cells  2023,12(3),460","journal-title":"Cells"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/metabo13091017","volume":"13","author":"Ding Y.","year":"2023","unstructured":"Ding Y.; Wang S.; Lu J.; Unlocking the potential: Amino acids\u2019 role in predicting and exploring therapeutic avenues for type 2 diabetes mellitus. Metabolites  2023,13(9),1017","journal-title":"Metabolites"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.3390\/cimb44120410","volume":"44","author":"Ola M.S.","year":"2022","unstructured":"Ola M.S.; Reduced tyrosine and serine-632 phosphorylation of insulin receptor substrate-1 in the gastrocnemius muscle of obese zucker rat. Curr Issues Mol Biol  2022,44(12),6015-6027","journal-title":"Curr Issues Mol Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13293-020-00328-1","volume":"11","author":"Luo H.H.","year":"2020","unstructured":"Luo H.H.; Feng X.F.; Yang X.L.; Hou R.Q.; Fang Z.Z.; Interactive effects of asparagine and aspartate homeostasis with sex and age for the risk of type 2 diabetes risk. Biol Sex Differ  2020,11(1),58","journal-title":"Biol Sex Differ"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/apm.12987","volume":"127","author":"Holm L.J.","year":"2019","unstructured":"Holm L.J.; Buschard K.; L-serine: A neglected amino acid with a potential therapeutic role in diabetes. Acta Pathol Microbiol Scand Suppl  2019,127(10),655-659","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"ref=56","first-page":"95","volume":"91","author":"Chen Y.","year":"2018","unstructured":"Chen Y.; Michalak M.; Agellon L.B.; Importance of nutrients and nutrient metabolism on human health. Yale J Biol Med  2018,91(2),95-103","journal-title":"Yale J Biol Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3892\/etm.2021.10138","volume":"22","author":"Shetty S.","year":"2021","unstructured":"Shetty S.; Kumari S.; Fatty acids and their role in type-2 diabetes (review). Exp Ther Med  2021,22(1),706","journal-title":"Exp Ther Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.plipres.2010.10.005","volume":"50","author":"Dobrian A.D.","year":"2011","unstructured":"Dobrian A.D.; Lieb D.C.; Cole B.K.; Taylor-Fishwick D.A.; Chakrabarti S.K.; Nadler J.L.; Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res  2011,50(1),115-131","journal-title":"Prog Lipid Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"101234","DOI":"10.1016\/j.molmet.2021.101234","volume":"52","author":"Milstein J.L.","year":"2021","unstructured":"Milstein J.L.; Ferris H.A.; The brain as an insulin-sensitive metabolic organ. Mol Metab  2021,52,101234","journal-title":"Mol Metab"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2015.09.019","volume":"418","author":"Magnan C.","year":"2015","unstructured":"Magnan C.; Levin B.E.; Luquet S.; Brain lipid sensing and the neural control of energy balance. Mol Cell Endocrinol  2015,418(Pt 1),3-8","journal-title":"Mol Cell Endocrinol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.3390\/ijms22115479","volume":"22","author":"Komarnytsky S.","year":"2021","unstructured":"Komarnytsky S.; Rathinasabapathy T.; Wagner C.; Metzger B.; Carlisle C.; Panda C.; Le Brun-Blashka S.; Troup J.P.; Varadharaj S.; Endocannabinoid system and its regulation by polyunsaturated fatty acids and full spectrum hemp oils. Int J Mol Sci  2021,22(11),5479","journal-title":"Int J Mol Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"Sies H.","year":"2020","unstructured":"Sies H.; Jones D.P.; Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol  2020,21(7),363-383","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"Giacco F.","year":"2010","unstructured":"Giacco F.; Brownlee M.; Oxidative stress and diabetic complications. Circ Res  2010,107(9),1058-1070","journal-title":"Circ Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/molecules27030950","volume":"27","author":"Singh A.","year":"2022","unstructured":"Singh A.; Kukreti R.; Saso L.; Kukreti S.; Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules  2022,27(3),950","journal-title":"Molecules"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"a009191","DOI":"10.1101\/cshperspect.a009191","volume":"6","author":"Boucher J.","year":"2014","unstructured":"Boucher J.; Kleinridders A.; Kahn C.R.; Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol  2014,6(1),a009191-a009191","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4331\/wjbc.v11.i3.76","volume":"11","author":"Wang T.","year":"2020","unstructured":"Wang T.; Wang J.; Hu X.; Huang X.; Chen G.X.; Current understanding of glucose transporter 4 expression and functional mechanisms. World J Biol Chem  2020,11(3),76-98","journal-title":"World J Biol Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.fshw.2023.03.021","volume":"12","author":"Miao L.","year":"2023","unstructured":"Miao L.; Zhang H.; Cheong M.S.; Zhong R.; Garcia-Oliveira P.; Prieto M.A.; Cheng K-W.; Wang M.; Cao H.; Nie S.; Simal-Gandara J.; Cheang W.S.; Xiao J.; Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K\/Akt\/Glut-4 signaling pathways in insulin-resistant HepG2 cells. Food Sci Hum Wellness  2023,12(6),1991-2000","journal-title":"Food Sci Hum Wellness"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1248\/bpb.b22-00913","volume":"46","author":"Ihim S.A.","year":"2023","unstructured":"Ihim S.A.; Kaneko Y.K.; Yamamoto M.; Yamaguchi M.; Kimura T.; Ishikawa T.; Apigenin alleviates endoplasmic reticulum stress-mediated apoptosis in INS-1 \u03b2-cells. Biol Pharm Bull  2023,46(4),630-635","journal-title":"Biol Pharm Bull"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"163","DOI":"10.21608\/bfsa.2022.239375","volume":"45","author":"Khallaf I.S.A.","year":"2022","unstructured":"Khallaf I.S.A.; Wahman R.; Farghaly H.S.M.; Bayoumi S.A.L.; The inhibitory effect of doum palm (Hyphaene thebaica L. Mart.) leaves extract on \u03b1-glucosidase activity. Bull Pharm Sci Assiut Univ  2022,45(1),163-176","journal-title":"Bull Pharm Sci Assiut Univ"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"107059","DOI":"10.1016\/j.bioorg.2023.107059","volume":"143","author":"Liu H.","year":"2024","unstructured":"Liu H.; Huang P.; Wang X.; Ma Y.; Tong J.; Li J.; Ding H.; Apigenin analogs as \u03b1-glucosidase inhibitors with antidiabetic activity. Bioorg Chem  2024,143,107059","journal-title":"Bioorg Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/fft2.192","volume":"4","author":"Miao L.","year":"2023","unstructured":"Miao L.; Cheong M.S.; Zhou C.; Farag M.; Cheang W.S.; Xiao J.; Apigenin alleviates diabetic endothelial dysfunction through activating AMPK\/PI3K\/Akt\/eNOS and Nrf2\/HO-1 signaling pathways. Food Front  2023,4(1),420-431","journal-title":"Food Front"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3844\/ajptsp.2014.39.52","volume":"9","author":"Hossain C.M.","year":"2014","unstructured":"Hossain C.M.; Ghosh M.K.; Satapathy B.S.; Dey N.S.; Mukherjee B.; Apigenin causes biochemical modulation, GLUT4 and CD38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am J Pharmacol Toxicol  2014,9(1),39-52","journal-title":"Am J Pharmacol Toxicol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.2147\/IJN.S256494","volume":"15","author":"Li P.","year":"2020","unstructured":"Li P.; Bukhari S.N.A.; Khan T.; Chitti R.; Bevoor D.B.; Hiremath A.R.; SreeHarsha N.; Singh Y.; Gubbiyappa K.S.; Apigenin-loaded solid lipid nanoparticle attenuates diabetic nephropathy induced by streptozotocin nicotinamide through Nrf2\/HO-1\/NF-kB signalling pathway. Int J Nanomedicine  2020,15,9115-9124","journal-title":"Int J Nanomedicine"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"148107","DOI":"10.1016\/j.gene.2023.148107","volume":"898","author":"Gamal Sherif S.","year":"2024","unstructured":"Gamal Sherif S.; Tarek M.; Gamal Sabry Y.; Hassan Abou Ghalia A.; Effect of apigenin on dynamin-related protein 1 in type 1 diabetic rats with cardiovascular complications. Gene  2024,898,148107","journal-title":"Gene"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/ph16070975","volume":"16","author":"Han M.","year":"2023","unstructured":"Han M.; Lu Y.; Tao Y.; Zhang X.; Dai C.; Zhang B.; Xu H.; Li J.; Luteolin protects pancreatic \u03b2 cells against apoptosis through regulation of autophagy and ROS clearance. Pharmaceuticals (Basel)  2023,16(7),975","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1080\/09168451.2015.1116928","volume":"80","author":"Zang Y.","year":"2016","unstructured":"Zang Y.; Igarashi K.; Li Y.; Anti-diabetic effects of luteolin and luteolin-7-O-glucoside on KK-A(y) mice. Biosci Biotechnol Biochem  2016,80(8),1580-1586","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"323171","DOI":"10.1155\/2011\/323171","volume":"2011","author":"Wang G.G.","year":"2011","unstructured":"Wang G.G.; Lu X.H.; Li W.; Zhao X.; Zhang C.; Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid Based Complement Alternat Med  2011,2011(1),323171","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4103\/2221-1691.391156","volume":"13","author":"Daude R.B.","year":"2023","unstructured":"Daude R.B.; Bhadane R.; Shah J.S.; Luteolin attenuates diabetic nephropathy via inhibition of metalloenzymes in rats. Asian Pac J Trop Biomed  2023,13(12),507-520","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"03946320221137435","DOI":"10.1177\/03946320221137435","volume":"36","author":"Ahmed E.S.A.","year":"2022","unstructured":"Ahmed E.S.A.; Mohamed H.E.; Farrag M.A.; Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K\/AKT\/FoxO1 pathway. Int J Immunopathol Pharmacol  2022,36,03946320221137435","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jare.2022.06.003","volume":"46","author":"Ge X.","year":"2023","unstructured":"Ge X.; He X.; Liu J.; Zeng F.; Chen L.; Xu W.; Shao R.; Huang Y.; Farag M.A.; Capanoglu E.; El-Seedi H.R.; Zhao C.; Liu B.; Amelioration of type 2 diabetes by the novel 6, 8-guanidyl luteolin quinone-chromium coordination via biochemical mechanisms and gut microbiota interaction. J Adv Res  2023,46,173-188","journal-title":"J Adv Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/a-0998-7985","volume":"129","author":"Zhang M.","year":"2021","unstructured":"Zhang M.; He L.; Liu J.; Zhou L.; Luteolin attenuates diabetic nephropathy through suppressing inflammatory response and oxidative stress by inhibiting STAT3 pathway. Exp Clin Endocrinol Diabetes  2021,129(10),729-739","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/jfb14030126","volume":"14","author":"Kahksha A.O.","year":"2023","unstructured":"Kahksha A.O.; Alam O.; Al-Keridis L.A.; Khan J.; Naaz S.; Alam A.; Ashraf S.A.; Alshammari N.; Adnan M.; Beg M.A.; Evaluation of antidiabetic effect of luteolin in stz induced diabetic rats: Molecular docking, molecular dynamics, in vitro and in vivo studies. J Funct Biomater  2023,14(3),126","journal-title":"J Funct Biomater"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41387-019-0095-8","volume":"9","author":"Li S.","year":"2019","unstructured":"Li S.; Zhang Y.; Sun Y.; Zhang G.; Bai J.; Guo J.; Su X.; Du H.; Cao X.; Yang J.; Wang T.; Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK. Nutr Diabetes  2019,9(1),28","journal-title":"Nutr Diabetes"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1039\/C9FO00881K","volume":"11","author":"Singh P.","year":"2020","unstructured":"Singh P.; Bansal S.; Kuhad A.; Kumar A.; Chopra K.; Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels. Food Funct  2020,11(5),4548-4560","journal-title":"Food Funct"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1900224","DOI":"10.1002\/mnfr.201900224","volume":"63","author":"Nguyen-Ngo C.","year":"2019","unstructured":"Nguyen-Ngo C.; Willcox J.C.; Lappas M.; Anti-diabetic, anti-inflammatory, and anti-oxidant effects of naringenin in an in vitro human model and an in vivo murine model of gestational diabetes mellitus. Mol Nutr Food Res  2019,63(19),1900224","journal-title":"Mol Nutr Food Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.4142\/jvs.2021.22.e92","volume":"22","author":"Dayarathne L.A.","year":"2021","unstructured":"Dayarathne L.A.; Ranaweera S.S.; Natraj P.; Rajan P.; Lee Y.J.; Han C.H.; The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells. J Vet Sci  2021,22(6),e92","journal-title":"J Vet Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5582\/ddt.2019.01034","volume":"13","author":"Zaidun N.H.","year":"2019","unstructured":"Zaidun N.H.; Sahema Z.C.T.; Mardiana A.A.; Santhana R.L.; Latiff A.A.; Syed Ahmad Fuad S.B.; Effects of naringenin on vascular changes in prolonged hyperglycaemia in fructose-STZ diabetic rat model. Drug Discov Ther  2019,13(4),212-221","journal-title":"Drug Discov Ther"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3389\/fphar.2018.01562","volume":"9","author":"Rajappa R.","year":"2019","unstructured":"Rajappa R.; Sireesh D.; Salai M.B.; Ramkumar K.M.; Sarvajayakesavulu S.; Madhunapantula S.V.; Treatment with naringenin elevates the activity of transcription factor Nrf2 to protect pancreatic \u03b2-cells from streptozotocin-induced diabetes in vitro and in vivo. Front Pharmacol  2019,9,1562","journal-title":"Front Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cbi.2013.12.014","volume":"210","author":"Priscilla D.H.","year":"2014","unstructured":"Priscilla D.H.; Roy D.; Suresh A.; Kumar V.; Thirumurugan K.; Naringenin inhibits \u03b1-glucosidase activity: A promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem Biol Interact  2014,210,77-85","journal-title":"Chem Biol Interact"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jff.2015.02.005","volume":"14","author":"Priscilla D.H.","year":"2015","unstructured":"Priscilla D.H.; Jayakumar M.; Thirumurugan K.; Flavanone naringenin: An effective antihyperglycemic and antihyperlipidemic nutraceutical agent on high fat diet fed streptozotocin induced type 2 diabetic rats. J Funct Foods  2015,14,363-373","journal-title":"J Funct Foods"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"e13422","DOI":"10.1111\/jfbc.13422","volume":"44","author":"Rehman K.","year":"2020","unstructured":"Rehman K.; Khan I.I.; Akash M.S.H.; Jabeen K.; Haider K.; Naringenin downregulates inflammation-mediated nitric oxide overproduction and potentiates endogenous antioxidant status during hyperglycemia. J Food Biochem  2020,44(10),e13422","journal-title":"J Food Biochem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.carbpol.2017.04.066","volume":"170","author":"Maity S.","year":"2017","unstructured":"Maity S.; Mukhopadhyay P.; Kundu P.P.; Chakraborti A.S.; Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals - An in vitro and in vivo approach. Carbohydr Polym  2017,170,124-132","journal-title":"Carbohydr Polym"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biopha.2017.10.102","volume":"97","author":"Jayaraman R.","year":"2018","unstructured":"Jayaraman R.; Subramani S.; Sheik Abdullah S.H.; Udaiyar M.; Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin-induced diabetic rats. Biomed Pharmacother  2018,97,98-106","journal-title":"Biomed Pharmacother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1248\/bpb.b20-00849","volume":"44","author":"Yoshida H.","year":"2021","unstructured":"Yoshida H.; Tsuhako R.; Sugita C.; Kurokawa M.; Glucosyl hesperidin has an anti-diabetic effect in high-fat diet-induced obese mice. Biol Pharm Bull  2021,44(3),422-430","journal-title":"Biol Pharm Bull"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4162\/nrp.2021.15.5.591","volume":"15","author":"Lee A.","year":"2021","unstructured":"Lee A.; Gu H.; Gwon M.H.; Yun J.M.; Hesperetin suppresses LPS\/high glucose-induced inflammatory responses via TLR\/MyD88\/NF-\u03baB signaling pathways in THP-1 cells. Nutr Res Pract  2021,15(5),591-603","journal-title":"Nutr Res Pract"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/foods13071068","volume":"13","author":"Ji X.","year":"2024","unstructured":"Ji X.; Zhang C.; Yang J.; Tian Y.; You L.; Yang H.; Li Y.; Liu H.; Pan D.; Liu Z.; Kaempferol improves exercise performance by regulating glucose uptake, mitochondrial biogenesis, and protein synthesis via PI3K\/AKT and MAPK signaling pathways. Foods  2024,13(7),1068","journal-title":"Foods"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"13720","DOI":"10.1021\/acs.jafc.0c05236","volume":"68","author":"Kitakaze T.","year":"2020","unstructured":"Kitakaze T.; Jiang H.; Nomura T.; Hironao K.; Yamashita Y.; Ashida H.; Kaempferol promotes glucose uptake in myotubes through a JAK2-dependent pathway. J Agric Food Chem  2020,68(47),13720-13729","journal-title":"J Agric Food Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejphar.2011.08.011","volume":"670","author":"Zhang Y.","year":"2011","unstructured":"Zhang Y.; Liu D.; Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol  2011,670(1),325-332","journal-title":"Eur J Pharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"115788","DOI":"10.1016\/j.jep.2022.115788","volume":"301","author":"Kashyap B.","year":"2023","unstructured":"Kashyap B.; Saikia K.; Samanta S.K.; Thakur D.; Banerjee S.K.; Borah J.C.; Talukdar N.C.; Kaempferol 3-O-rutinoside from Antidesma acidum Retz. Stimulates glucose uptake through SIRT1 induction followed by GLUT4 translocation in skeletal muscle L6 cells. J Ethnopharmacol  2023,301,115788","journal-title":"J Ethnopharmacol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/molecules23092338","volume":"23","author":"Alkhalidy H.","year":"2018","unstructured":"Alkhalidy H.; Moore W.; Wang Y.; Luo J.; McMillan R.P.; Zhen W.; Zhou K.; Liu D.; The flavonoid kaempferol ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production. Molecules  2018,23(9),2338","journal-title":"Molecules"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fphar.2017.00336","volume":"8","author":"Dhanya R.","year":"2017","unstructured":"Dhanya R.; Arya A.D.; Nisha P.; Jayamurthy P.; Quercetin, a lead compound against type 2 diabetes ameliorates glucose uptake via AMPK pathway in skeletal muscle cell line. Front Pharmacol  2017,8,336","journal-title":"Front Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"e13127","DOI":"10.1111\/jfbc.13127","volume":"44","author":"Oyedemi S.O.","year":"2020","unstructured":"Oyedemi S.O.; Nwaogu G.; Chukwuma C.I.; Adeyemi O.T.; Matsabisa M.G.; Swain S.S.; Aiyegoro O.A.; Quercetin modulates hyperglycemia by improving the pancreatic antioxidant status and enzymes activities linked with glucose metabolism in type 2 diabetes model of rats: In silico studies of molecular interaction of quercetin with hexokinase and catalase. J Food Biochem  2020,44(2),e13127","journal-title":"J Food Biochem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1080\/01635581.2018.1470654","volume":"70","author":"Yarahmadi A.","year":"2018","unstructured":"Yarahmadi A.; Khademi F.; Mostafavi-Pour Z.; Zal F.; In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection). Nutr Cancer  2018,70(5),770-775","journal-title":"Nutr Cancer"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4162\/nrp.2012.6.3.201","volume":"6","author":"Jeong S.M.","year":"2012","unstructured":"Jeong S.M.; Kang M.J.; Choi H.N.; Kim J.H.; Kim J.I.; Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db\/db mice. Nutr Res Pract  2012,6(3),201-207","journal-title":"Nutr Res Pract"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"113108","DOI":"10.1016\/j.biopha.2022.113108","volume":"151","author":"Dong B.","year":"2022","unstructured":"Dong B.; Shi Z.; Dong Y.; Chen J.; Wu Z.X.; Wu W.; Chen Z.S.; Han C.; Quercetin ameliorates oxidative stress-induced cell apoptosis of seminal vesicles via activating Nrf2 in type 1 diabetic rats. Biomed Pharmacother  2022,151,113108","journal-title":"Biomed Pharmacother"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2014.06.005","volume":"109","author":"Alam M.M.","year":"2014","unstructured":"Alam M.M.; Meerza D.; Naseem I.; Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci  2014,109(1),8-14","journal-title":"Life Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3164\/jcbn.20-47","volume":"67","author":"Jiang H.","year":"2020","unstructured":"Jiang H.; Horiuchi Y.; Hironao K.; Kitakaze T.; Yamashita Y.; Ashida H.; Prevention effect of quercetin and its glycosides on obesity and hyperglycemia through activating AMPK\u03b1 in high-fat diet-fed ICR mice. J Clin Biochem Nutr  2020,67(1),75-83","journal-title":"J Clin Biochem Nutr"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8492780","volume":"2016","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Dong H.; Wang M.; Zhang J.; Quercetin isolated from Toona sinensis leaves attenuates hyperglycemia and protects hepatocytes in high-carbohydrate\/high-fat diet and alloxan induced experimental diabetic mice. J Diabetes Res  2016,2016,1-10","journal-title":"J Diabetes Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4162\/nrp.2011.5.2.107","volume":"5","author":"Kim J.H.","year":"2011","unstructured":"Kim J.H.; Kang M.J.; Choi H.N.; Jeong S.M.; Lee Y.M.; Kim J.I.; Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract  2011,5(2),107-111","journal-title":"Nutr Res Pract"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.biopha.2017.05.086","volume":"92","author":"Gaballah H.H.","year":"2017","unstructured":"Gaballah H.H.; Zakaria S.S.; Mwafy S.E.; Tahoon N.M.; Ebeid A.M.; Mechanistic insights into the effects of quercetin and\/or GLP-1 analogue liraglutide on high-fat diet\/streptozotocin-induced type 2 diabetes in rats. Biomed Pharmacother  2017,92,331-339","journal-title":"Biomed Pharmacother"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3417306","volume":"2017","author":"Peng J.","year":"2017","unstructured":"Peng J.; Li Q.; Li K.; Zhu L.; Lin X.; Lin X.; Shen Q.; Li G.; Xie X.; Quercetin improves glucose and lipid metabolism of diabetic rats: Involvement of Akt signaling and SIRT1. J Diabetes Res  2017,2017,1-10","journal-title":"J Diabetes Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9410","volume":"20","author":"Zhang F.","year":"2020","unstructured":"Zhang F.; Feng J.; Zhang J.; Kang X.; Qian D.; Quercetin modulates AMPK\/SIRT1\/NF-\u03baB signaling to inhibit inflammatory\/oxidative stress responses in diabetic high fat diet-induced atherosclerosis in the rat carotid artery. Exp Ther Med  2020,20(6),1","journal-title":"Exp Ther Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4062\/biomolther.2017.254","volume":"26","author":"Yang D.K.","year":"2018","unstructured":"Yang D.K.; Kang H.S.; Anti-diabetic effect of cotreatment with quercetin and resveratrol in streptozotocin-induced diabetic rats. Biomol Ther (Seoul)  2018,26(2),130-138","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1096\/fj.201601339R","volume":"31","author":"Li Y.","year":"2017","unstructured":"Li Y.; Zheng X.; Yi X.; Liu C.; Kong D.; Zhang J.; Gong M.; Myricetin: A potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist. FASEB J  2017,31(6),2603-2611","journal-title":"FASEB J"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"113530","DOI":"10.1016\/j.biopha.2022.113530","volume":"153","author":"Zhao Z.","year":"2022","unstructured":"Zhao Z.; Chen Y.; Li X.; Zhu L.; Wang X.; Li L.; Sun H.; Han X.; Li J.; Myricetin relieves the symptoms of type 2 diabetes mice and regulates intestinal microflora. Biomed Pharmacother  2022,153,113530","journal-title":"Biomed Pharmacother"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4093\/dmj.2018.0052","volume":"43","author":"Karunakaran U.","year":"2019","unstructured":"Karunakaran U.; Elumalai S.; Moon J.S.; Jeon J.H.; Kim N.D.; Park K.G.; Won K.C.; Leem J.; Lee I.K.; Myricetin protects against high glucose-induced \u03b2-cell apoptosis by attenuating endoplasmic reticulum stress via inactivation of cyclin-dependent kinase 5. Diabetes Metab J  2019,43(2),192-205","journal-title":"Diabetes Metab J"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/fft2.152","volume":"3","author":"Yang L.","year":"2022","unstructured":"Yang L.; Gao Y.; Gong J.; Wang H.; Farag M.A.; Simal-Gandara J.; Zhao Y.; Nie S.; Xiao J.; Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction. Food Front  2022,3(4),749-772","journal-title":"Food Front"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s10068-015-0249-y","volume":"24","author":"Kang S.J.","year":"2015","unstructured":"Kang S.J.; Park J.H.Y.; Choi H.N.; Kim J.I.; \u03b1-glucosidase inhibitory activities of myricetin in animal models of diabetes mellitus. Food Sci Biotechnol  2015,24(5),1897-1900","journal-title":"Food Sci Biotechnol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/13813455.2020.1808019","volume":"129","author":"Nallappan D.","year":"2023","unstructured":"Nallappan D.; Ong K.C.; Palanisamy U.D.; Chua K.H.; Kuppusamy U.R.; Myricetin derivative-rich fraction from Syzygium malaccense prevents high-fat diet-induced obesity, glucose intolerance and oxidative stress in C57BL\/6J mice. Arch Physiol Biochem  2023,129(1),186-197","journal-title":"Arch Physiol Biochem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ph15020173","volume":"15","author":"Li Y.X.","year":"2022","unstructured":"Li Y.X.; Cheng K.C.; Liu I.M.; Niu H.S.; Myricetin increases circulating adropin level after activation of Glucagon-like Peptide 1 (GLP-1) receptor in type-1 diabetic rats. Pharmaceuticals (Basel)  2022,15(2),173","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e0231543","DOI":"10.1371\/journal.pone.0231543","volume":"15","author":"Lalitha N.","year":"2020","unstructured":"Lalitha N.; Sadashivaiah B.; Ramaprasad T.R.; Singh S.A.; Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein. PLoS One  2020,15(4),e0231543","journal-title":"PLoS One"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/15569527.2019.1588289","volume":"38","author":"Ahiskali I.","year":"2019","unstructured":"Ahiskali I.; Pinar C.L.; Kiki M.; Mammadov R.; Ozbek Bilgin A.; Hacimuftuoglu A.; Cankaya M.; Keskin Cimen F.; Altuner D.; Effect of taxifolin on development of retinopathy in alloxan-induced diabetic rats. Cutan Ocul Toxicol  2019,38(3),227-232","journal-title":"Cutan Ocul Toxicol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"115936","DOI":"10.1016\/j.jep.2022.115936","volume":"303","author":"Gurumayum S.","year":"2023","unstructured":"Gurumayum S.; Bharadwaj S.; Sheikh Y.; Barge S.R.; Saikia K.; Swargiary D.; Ahmed S.A.; Thakur D.; Borah J.C.; Taxifolin-3-O-glucoside from Osbeckia nepalensis Hook. mediates antihyperglycemic activity in CC1 hepatocytes and in diabetic Wistar rats via regulating AMPK\/G6Pase\/PEPCK signaling axis. J Ethnopharmacol  2023,303,115936","journal-title":"J Ethnopharmacol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.3390\/ijms241511962","volume":"24","author":"Taldaev A.","year":"2023","unstructured":"Taldaev A.; Savina A.D.; Olicheva V.V.; Ivanov S.V.; Terekhov R.P.; Ilyasov I.R.; Zhevlakova A.K.; Selivanova I.A.; Protective properties of spheroidal taxifolin form in streptozotocin-induced diabetic rats. Int J Mol Sci  2023,24(15),11962","journal-title":"Int J Mol Sci"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cimb43030092","volume":"43","author":"Kondo S.","year":"2021","unstructured":"Kondo S.; Adachi S.; Yoshizawa F.; Yagasaki K.; Antidiabetic effect of taxifolin in cultured l6 myotubes and type 2 diabetic model kk-ay\/ta mice with hyperglycemia and hyperuricemia. Curr Issues Mol Biol  2021,43(3),1293-1306","journal-title":"Curr Issues Mol Biol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jcb.27398","volume":"120","author":"Rehman K.","year":"2019","unstructured":"Rehman K.; Chohan T.A.; Waheed I.; Gilani Z.; Akash M.S.H.; Taxifolin prevents postprandial hyperglycemia by regulating the activity of \u03b1-amylase: Evidence from an in vivo and in silico studies. J Cell Biochem  2019,120(1),425-438","journal-title":"J Cell Biochem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/scipharm87030020","volume":"87","author":"Lengyel M.","year":"2019","unstructured":"Lengyel M.; K\u00e1llai-Szab\u00f3 N.; Antal V.; Laki A.J.; Antal I.; Microparticles, microspheres, and microcapsules for advanced drug delivery. Sci Pharm  2019,87(3),20","journal-title":"Sci Pharm"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"106704","DOI":"10.1016\/j.ejps.2024.106704","volume":"194","author":"K\u00e1llai-Szab\u00f3 N.","year":"2024","unstructured":"K\u00e1llai-Szab\u00f3 N.; Farkas D.; Lengyel M.; Basa B.; Fleck C.; Antal I.; Microparticles and multi-unit systems for advanced drug delivery. Eur J Pharm Sci  2024,194,106704","journal-title":"Eur J Pharm Sci"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2174\/1574885518666230726142855","volume":"19","author":"Shukla S.","year":"2024","unstructured":"Shukla S.; Pandit V.; Trojan microparticles : A composite nanoparticle delivery system. Curr Drug Ther  2024,19(4),413-425","journal-title":"Curr Drug Ther"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015798","volume":"33","author":"Bale S.","year":"2016","unstructured":"Bale S.; Khurana A.; Reddy A.S.S.; Singh M.; Godugu C.; Overview on therapeutic applications of microparticulate drug delivery systems. Crit Rev Ther Drug Carrier Syst  2016,33(4),309-361","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"730","DOI":"10.34172\/apb.2022.075","volume":"12","author":"Rafiee M.H.","year":"2021","unstructured":"Rafiee M.H.; Abdul Rasool B.K.; An overview of microparticulate drug delivery system and its extensive therapeutic applications in diabetes. Adv Pharm Bull  2021,12(4),730-746","journal-title":"Adv Pharm Bull"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jscs.2012.12.009","volume":"18","author":"Safari J.","year":"2014","unstructured":"Safari J.; Zarnegar Z.; Advanced drug delivery systems: Nanotechnology of health design A review. J Saudi Chem Soc  2014,18(2),85-99","journal-title":"J Saudi Chem Soc"},{"key":"ref=133","first-page":"85","volume":"7","author":"Subramani K.","year":"2012","unstructured":"Subramani K.; Pathak S.; Hosseinkhani H.; Recent trends in diabetes treatment using nanotechnology. Dig J Nanomater Biostruct  2012,7(1),85-95","journal-title":"Dig J Nanomater Biostruct"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"10215","DOI":"10.2147\/IJN.S285134","volume":"15","author":"Nie X.","year":"2020","unstructured":"Nie X.; Chen Z.; Pang L.; Wang L.; Jiang H.; Chen Y.; Zhang Z.; Fu C.; Ren B.; Zhang J.; Oral nano drug delivery systems for the treatment of type 2 diabetes mellitus: An available administration strategy for antidiabetic phytocompounds. Int J Nanomedicine  2020,15,10215-10240","journal-title":"Int J Nanomedicine"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/wnan.1329","volume":"7","author":"DiSanto R.M.","year":"2015","unstructured":"DiSanto R.M.; Subramanian V.; Gu Z.; Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol  2015,7(4),548-564","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000351815","volume":"26","author":"Perumal O.","year":"2013","unstructured":"Perumal O.; Murthy S.N.; Kalia Y.N.; Turning theory into practice: The development of modern transdermal drug delivery systems and future trends. Skin Pharmacol Physiol  2013,26(4-6),331-342","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/B978-0-323-91668-4.00016-2","author":"Gupta D.K.","year":"2023","unstructured":"Gupta D.K.; Ahad A.; Aqil M.; Al-Mohizea A.M.; Al-Jenoobi F.I.; Chapter 18 - Iontophoretic drug delivery: Concepts, approaches, and applications. Advanced and Modern Approaches for Drug Delivery  2023,515-546","journal-title":"Advanced and Modern Approaches for Drug Delivery"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"109996","DOI":"10.1016\/j.diabres.2022.109996","volume":"194","author":"Thirunavukkarasu A.","year":"2022","unstructured":"Thirunavukkarasu A.; Nithya R.; Jeyanthi J.; Transdermal drug delivery systems for the effective management of type 2 diabetes mellitus: A review. Diabetes Res Clin Pract  2022,194,109996","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejpb.2016.03.019","volume":"103","author":"Yu F.","year":"2016","unstructured":"Yu F.; Li Y.; Chen Q.; He Y.; Wang H.; Yang L.; Guo S.; Meng Z.; Cui J.; Xue M.; Chen X.D.; Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. Eur J Pharm Biopharm  2016,103,136-148","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2337\/dci20-0065","volume":"43","author":"Riddle M.C.","year":"2020","unstructured":"Riddle M.C.; Philipson L.H.; Rich S.S.; Carlsson A.; Franks P.W.; Greeley S.A.W.; Nolan J.J.; Pearson E.R.; Zeitler P.S.; Hattersley A.T.; Monogenic Diabetes: From genetic insights to population-based precision in care. Reflections from a Diabetes Care editors' expert forum Diabetes Care  2020,43(12),3117-3128","journal-title":"Diabetes Care"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0098-2997(01)00004-8","volume":"22","author":"Rubanyi G.M.","year":"2001","unstructured":"Rubanyi G.M.; The future of human gene therapy. Mol Aspects Med  2001,22(3),113-142","journal-title":"Mol Aspects Med"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","volume":"525","author":"Wirth T.","year":"2013","unstructured":"Wirth T.; Parker N.; Yl\u00e4-Herttuala S.; History of gene therapy. Gene  2013,525(2),162-169","journal-title":"Gene"},{"key":"ref=143","first-page":"26","volume":"2","author":"Yong Z.","year":"2022","unstructured":"Yong Z.; Application of Gene therapy in the perspective of the therapy of type 2 diabetes mellitus. J Biomed Biosens  2022,2(1),26-31","journal-title":"J Biomed Biosens"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/cells9020283","volume":"9","author":"Memon B.","year":"2020","unstructured":"Memon B.; Abdelalim E.M.; Stem cell therapy for diabetes: Beta cells versus pancreatic progenitors. Cells  2020,9(2),283","journal-title":"Cells"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"631463","DOI":"10.3389\/fendo.2021.631463","volume":"12","author":"de Klerk E.","year":"2021","unstructured":"de Klerk E.; Hebrok M.; Stem cell-based clinical trials for diabetes mellitus. Front Endocrinol (Lausanne)  2021,12,631463","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13287-020-01793-6","volume":"11","author":"Chen S.","year":"2020","unstructured":"Chen S.; Du K.; Zou C.; Current progress in stem cell therapy for type 1 diabetes mellitus. Stem Cell Res Ther  2020,11(1),275","journal-title":"Stem Cell Res Ther"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14336\/AD.2019.0421","volume":"11","author":"Yazhen Z.","year":"2020","unstructured":"Yazhen Z.; Wenyi C.; Bing F.; Hongcui C.; The clinical efficacy and safety of stem cell therapy for diabetes mellitus: A systematic review and meta-analysis. Aging Dis  2020,11(1),141-153","journal-title":"Aging Dis"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/cells9010252","volume":"9","author":"Riess M.L.","year":"2020","unstructured":"Riess M.L.; Elorbany R.; Weihrauch D.; Stowe D.F.; Camara A.K.S.; PPAR\u03b3-independent side effects of thiazolidinediones on mitochondrial redox state in rat isolated hearts. Cells  2020,9(1),252","journal-title":"Cells"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fendo.2020.00178","volume":"11","author":"Gilbert M.P.","year":"2020","unstructured":"Gilbert M.P.; Pratley R.E.; GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: Review of head-to-head clinical trials. Front Endocrinol (Lausanne)  2020,11,178","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"e1800025","DOI":"10.1002\/cbdv.201800025","volume":"15","author":"Somtimuang C.","year":"2018","unstructured":"Somtimuang C.; Olatunji O.J.; Ovatlarnporn C.; Evaluation of in vitro \u03b1-amylase and \u03b1 -glucosidase inhibitory potentials of 14 medicinal plants constituted in thai folk antidiabetic formularies. Chem Biodivers  2018,15(4),e1800025","journal-title":"Chem Biodivers"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"118239","DOI":"10.1016\/j.jep.2024.118239","volume":"330","author":"Benjamin M.A.Z.","year":"2024","unstructured":"Benjamin M.A.Z.; Mohd Mokhtar R.A.; Iqbal M.; Abdullah A.; Azizah R.; Sulistyorini L.; Mahfudh N.; Zakaria Z.A.; Medicinal plants of Southeast Asia with anti-\u03b1-glucosidase activity as potential source for type-2 diabetes mellitus treatment. J Ethnopharmacol  2024,330,118239","journal-title":"J Ethnopharmacol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.3390\/molecules25225243","volume":"25","author":"Ullah A.","year":"2020","unstructured":"Ullah A.; Munir S.; Badshah S.L.; Khan N.; Ghani L.; Poulson B.G.; Emwas A.H.; Jaremko M.; Important flavonoids and their role as a therapeutic agent. Molecules  2020,25(22),5243","journal-title":"Molecules"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.2174\/1875533XMTExDNzIt5","volume":"28","author":"El-Nashar H.A.S.","year":"2021","unstructured":"El-Nashar H.A.S.; Mostafa N.M.; El-Shazly M.; Eldahshan O.A.; The role of plant-derived compounds in managing diabetes mellitus: A review of literature from 2014 to 2019. Curr Med Chem  2021,28(23),4694-4730","journal-title":"Curr Med Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/molecules26175377","volume":"26","author":"Dias M.C.","year":"2021","unstructured":"Dias M.C.; Pinto D.C.G.A.; Silva A.M.S.; Plant flavonoids: Chemical characteristics and biological activity. Molecules  2021,26(17),5377","journal-title":"Molecules"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1039\/C4FO01178C","volume":"6","author":"Kawabata K.","year":"2015","unstructured":"Kawabata K.; Mukai R.; Ishisaka A.; Quercetin and related polyphenols: New insights and implications for their bioactivity and bioavailability. Food Funct  2015,6(5),1399-1417","journal-title":"Food Funct"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s40495-021-00269-2","volume":"8","author":"Agraharam G.","year":"2022","unstructured":"Agraharam G.; Girigoswami A.; Girigoswami K.; Myricetin: A multifunctional flavonol in biomedicine. Curr Pharmacol Rep  2022,8(1),48-61","journal-title":"Curr Pharmacol Rep"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00216-011-5504-3","volume":"402","author":"Rame\u0161ov\u00e1 \u0160.","year":"2012","unstructured":"Rame\u0161ov\u00e1 \u0160.; Sokolov\u00e1 R.; Degano I.; Bul\u00ed\u010dkov\u00e1 J.; \u017dabka J.; G\u00e1l M.; On the stability of the bioactive flavonoids quercetin and luteolin under oxygen-free conditions. Anal Bioanal Chem  2012,402(2),975-982","journal-title":"Anal Bioanal Chem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1221227","DOI":"10.3389\/fnut.2023.1221227","volume":"10","author":"Chen P.","year":"2023","unstructured":"Chen P.; Chen F.; Guo Z.; Lei J.; Zhou B.; Recent advancement in bioeffect, metabolism, stability, and delivery systems of apigenin, a natural flavonoid compound: challenges and perspectives. Front Nutr  2023,10,1221227","journal-title":"Front Nutr"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"114990","DOI":"10.1016\/j.biopha.2023.114990","volume":"164","author":"Cai J.","year":"2023","unstructured":"Cai J.; Wen H.; Zhou H.; Zhang D.; Lan D.; Liu S.; Li C.; Dai X.; Song T.; Wang X.; He Y.; He Z.; Tan J.; Zhang J.; Naringenin: A flavanone with anti-inflammatory and anti-infective properties. Biomed Pharmacother  2023,164,114990","journal-title":"Biomed Pharmacother"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"118642","DOI":"10.1016\/j.ijpharm.2019.118642","volume":"570","author":"Zhao J.","year":"2019","unstructured":"Zhao J.; Yang J.; Xie Y.; Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. Int J Pharm  2019,570,118642","journal-title":"Int J Pharm"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.3390\/plants12142732","volume":"12","author":"Liga S.","year":"2023","unstructured":"Liga S.; Paul C.; P\u00e9ter F.; Flavonoids: Overview of biosynthesis, biological activity, and current extraction techniques. Plants  2023,12(14),2732","journal-title":"Plants"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1007\/s11064-023-03986-w","volume":"48","author":"Lotfi M.S.","year":"2023","unstructured":"Lotfi M.S.; Kalalinia F.; Flavonoids in combination with stem cells for the treatment of neurological disorders. Neurochem Res  2023,48(11),3270-3282","journal-title":"Neurochem Res"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733998335480241022084655","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/236648\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733998335480241022084655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:04:10Z","timestamp":1772085850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/236648\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":162,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115733998335480241022084655","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15733998335480"}}